Protective effect of gan mai da zao decoction in unpredictable chronic mild stress-induced behavioral and biochemical alterations

Pharmaceutical Biology

Volumn 48, Issue 12, 2010, Pages 1328-1336

  Lou, Jian Shu ^a   Li, Chang Yu ^b   Yang, Xiao Chun ^a   Fang, Jie ^a   Yang, Yuan Xiao ^b   Guo, Jian You ^c  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

^c INSTITUTE OF PSYCHOLOGY   (China)

Author keywords

Depression; Gan mai da zao decoction; Glutamate; N methyl D aspartate receptor; Unpredictable chronic mild stress

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; GAN MAI DA ZAO; GLUTAMIC ACID; HERBACEOUS AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; UNCLASSIFIED DRUG;

AMINO ACID BRAIN LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOCHEMISTRY; CHRONIC STRESS; CONTROLLED STUDY; DEPRESSION; DRUG MEGADOSE; FRONTAL CORTEX; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; LOW DRUG DOSE; MALE; NEUROPROTECTION; NONHUMAN; OPEN FIELD TEST; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ANIMALS; BEHAVIOR, ANIMAL; BLOTTING, WESTERN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHRONIC DISEASE; DEPRESSION; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; FRONTAL LOBE; GLUTAMIC ACID; HIPPOCAMPUS; MALE; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; STRESS, PSYCHOLOGICAL; SUCROSE;

RATTUS;

EID: 78649390297     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880201003789440     Document Type: Article

References (35)

1. Begley DJ, Reichel A, Ermisch A (1994): Simple high-performance liquid chromatographic analysis of free primary amino acid concentrations in rat plasma and cisternal cerebrospinal fuid. J Chromatogr B Biomed Appl 657: 185-191.
2. Beneyto M, Kristiansen LV, Oni-Orisan A, McCullumsmith RE, Meador-Woodruf JH (2007): Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders. Neuropsychopharmacology 32: 1888-1902.
3. Cassano P, Fava M (2004): Tolerability issues during long-term treatment with antidepressants. Ann Clin Psychiatry 16: 15-25.
4. Cunha RA, Ferré S, Vaugeois JM, Chen JF (2008): Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders. Curr Pharm Des 14: 1512-1524.
5. Feyissa AM, Chandran A, Stockmeier CA, Karolewicz B (2009): Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression. Prog Neuropsychopharmacol Biol Psychiatry 33: 70-75.
6. Fornal CA, Metzler CW, Mirescu C, Stein SK, Jacobs BL (2001): Efects of standardized extracts of St. John's wort on the single-unit activity of serotonergic dorsal Raphe neurons in awake cats: Comparisons with fuoxetine and sertraline. Neuropsychopharmacology 25: 858-870.
7. Greene JG, Greenamyre JT (1996): Bioenergetics and glutamate exci-totoxicity. Prog Neurobiol, 48, 613-634.
8. Guo JY, Huo HR, Li LF, Guo SY, Jiang TL (2009): Sini tang prevents depression-like behavior in rats exposed to chronic unpredictable stress. Am J Chin Med 37: 261-272.
9. Hashimoto K, Sawa A, Iyo M (2007): Increased levels of glutamate in brains from patients with mood disorders. Biol Psychiatry 62: 1310-1316.
10. He ZS, Yin YL, Hu YL, Huang RL, Kong XR, Li TJ, Li FW (2008): Efects of glycyrrhetinic acid on the growth, plasma hormone and amino acid level and hematology in milk-fed piglets. J Nanjing Agric Univ, 31, 111-115.
11. Huh KH, Wenthold RJ (1999): Turnover analysis of glutamate receptors identifes a rapidly degraded pool of the N-methyl-D-aspartate receptor subunit, NR1, in cultured cerebellar granule cells. J Biol Chem 274: 151-157.
12. Karolewicz B, Stockmeier CA, Ordway GA (2005): Elevated levels of the NR2C subunit of the NMDA receptor in the locus coeruleus in depression. Neuropsychopharmacology 30: 1557-1567.
13. Laurie DJ, Putzke J, Zieglgänsberger W, Seeburg PH, Tölle TR (1995): Te distribution of splice variants of the NMDAR1 subunit mRNA in adult rat brain. Brain Res Mol Brain Res 32: 94-108.
14. Maes M, Verkerk R, Vandoolaeghe E, Lin A, Scharpé S (1998): Serum levels of excitatory amino acids, serine, glycine, histidine, threonine, taurine, alanine and arginine in treatment-resistant depression: Modulation by treatment with antidepressants and prediction of clinical responsivity. Acta Psychiatr Scand 97: 302-308.
15. Maura G, Marcoli M, Pepicelli O, Rosu C, Viola C, Raiteri M (2000): Serotonin inhibition of the NMDA receptor/nitric oxide/cyclic GMP pathway in human neocortex slices: Involvement of 5-HT(2C) and 5-HT(1A) receptors. Br J Pharmacol 130: 1853-1858.
16. National Pharmacopoeia Committe (2005) Te People's Republic of China Pharmacopoeia. Beijing, China: Medical Science Publishing House.
17. National Research Council (1996) Guide for the Care and Use of Laboratory Animals. Washington, D.C.: National Academy Press.
18. Neyton J, Paoletti P (2006) Relating NMDA receptor function to receptor subunit composition: Limitations of the pharmacological approach. J Neurosci 26: 1331-1333.
19. Padovan CM, Guimaraes FS (2004): Antidepressant-like efects of NMDA-receptor antagonist injected into the dorsal hippocampus of rats. Pharmacol Biochem Behav 77: 15-19.
20. Pittaluga A, Raiteri L, Longordo F, Luccini E, Barbiero VS, Racagni G, Popoli M, Raiteri M (2007): Antidepressant treatments and function of glutamate ionotropic receptors mediating amine release in hippocampus. Neuropharmacology 53: 27-36.
21. Prybylowski K, Fu Z, Losi G, Hawkins LM, Luo J, Chang K, Wenthold RJ, Vicini S (2002): Relationship between availability of NMDA receptor subunits and their expression at the synapse. J Neurosci 22: 8902-8910.
22. Rosenberg DR, MacMaster FP, Mirza Y, Smith JM, Easter PC, Banerjee SP, Bhandari R, Boyd C, Lynch M, Rose M, Ivey J, Villafuerte RA, Moore GJ, Renshaw P (2005): Reduced anterior cingulate glutamate in pediatric major depression: A magnetic resonance spectroscopy study. Bio Psychiatry 58:700-704.
23. Rowland LM, Bustillo JR, Mullins PG, Jung RE, Lenroot R, Landgraf E, Barrow R, Yeo R, Lauriello J, Brooks WM (2005): Efects of keta-mine on anterior cingulate glutamate metabolism in healthy humans: A 4-T proton MRS study. Am J Psychiatry 162: 394-396.
24. Schildkraut JJ (1965): Te catecholamine hypothesis of afective disorders: A review of supporting evidence. Am J Psychiatry 122: 509-522.
25. Shen YH, Zhou Y, Zhang C, Liu RH, Su J, Liu XH, Zhang WD (2009): Antidepressant efects of methanol extract and fractions of Bacopa monnieri. Pharm Biol 47: 340-343.
26. Shuang J, De L, Ma QZ, Ba Y, NIu XL (2001): Infuence of licorice root extract on pig's fattening and content of muscular free amino acids in compound additive. J Inner Mongolia Agric Anim Husb 22: 75-79.
27. Suen PC, Wu K, Xu JL, Lin SY, Levine ES, Black IB (1998): NMDA receptor subunits in the postsynaptic density of rat brain: Expression and phosphorylation by endogenous protein kinases. Brain Res Mol Brain Res 59: 215-228.
28. Szasz BK, Mike A, Karoly R, Gerevich Z, Illes P, Vizi ES, Kiss JP (2007): Direct inhibitory efect of fuoxetine on N-methyl-D-aspartate receptors in the central nervous system. Biol Psychiatry 62: 1303-1309.
29. Wang C, Wang Y, Zhao Z (2000): Peripheral NMDA and non-NMDA receptors contribute to nociception: An electrophysiological study. Brain Res Bull 52: 31-34.
30. Willner P (2005): Chronic mild stress (CMS) revisited: Consistency and behavioural-neurobiological concordance in the efects of CMS. Neuropsychobiology 52: 90-110.
31. Willner P, Towell A, Sampson D, Sophokleous S, Muscat R (1987): Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology (Berl) 93: 358-364.
32. Wu J (2002): Antidepressant efect of gan-mai-da-zao tang on depression compared with fuoxetine. J Chinese Physician 30: 18-19.
33. Yamakura T, Shimoji K (1999): Subunit-and site-specifc pharmacology of the NMDA receptor channel. Prog Neurobiol 59: 279-298.
34. Yang FE, Qiao QF, Gong YP (2009): Antidepressant efect of gan-mai-da-zao tang on 30 women with postpartum depression. Shanxi J TCM 30: 851-852.
35. Zarate CA Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK (2006): A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63: 856-864.